Funder
National Institutes of Health
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,General Medicine,Biotechnology
Reference213 articles.
1. U.S. Food and Drug Administration. Guidance for Industry: Immunogenicity Assessment for Therapeutic Protein Products. Silver Spring, MD: FDA; 2014. https://www.fda.gov/downloads/drugs/guidances/ucm338856.pdf Accessed 12 Jun 2020.
2. De Groot AS, Scott DW. Immunogenicity of protein therapeutics. Trends Immunol. 2007;28(11):482–90. https://doi.org/10.1016/j.it.2007.07.011.
3. Lee CA, Kessler CM, Varon D, Martinowitz U, Heim M, Jacquemin MG, et al. Factor VIII immunogenicity. Haemophilia. 1998;4(4):552–7. https://doi.org/10.1046/j.1365-2516.1998.440552.x.
4. Tieu P, Chan A, Matino D. Molecular mechanisms of inhibitor development in hemophilia. Mediterr J Hematol Infect Dis. 2020;12(1):e2020001. https://doi.org/10.4084/mjhid.2020.001.
5. Lee CA, Kessler CM, Varon D, Martinowitz U, Heim M, Hay CRM. Factor VIII inhibitors in mild and moderate-severity haemophilia A. Haemophilia. 1998;4(4):558–63. https://doi.org/10.1046/j.1365-2516.1998.440558.x.
Cited by
56 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献